explore -WSS

explore

author：focus 2025-09-30 09:31:18 - browse：6

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Feds fine Medicare Advantage plans for overcharging members

WSS

AstraZeneca challenges Medicare drug negotiation program

AstraZeneca challenges Medicare drug negotiation program

Australia’s approach to dialysis celebrates life

Biden will tout long

How to make Best Hospitals ratings actually useful for patients

Study finds new variant for Parkinson’s in African populations

hotspot

explore

explore

Guidelines to prevent youth baseball injuries need more muscle

What do new weight loss drugs mean for bariatric surgery?

Virginia high school admissions case could be legal follow

'The Exorcist' director William Friedkin dead at 87

Supreme Court strikes down use of affirmative action

Mississippi candidates for statewide offices square off in party primaries

Virginia high school admissions case could be legal follow

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Hepatitis C has a cure — but many Americans still lack access to it

Study finds new variant for Parkinson’s in African populations

entertainment

South Korea begins evacuating thousands of Scouts from coastal campsite as tropical storm nears

Psilocybin's anti

NYC plans to house migrants on an island in the East River

Illinois to ban advertising for guns allegedly marketed to kids and militants

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

How to make AI work for medicine

hotspot

hotspot

leisure time

hotspot